Journal of
Microbiology and Antimicrobials

  • Abbreviation: J. Microbiol. Antimicrob.
  • Language: English
  • ISSN: 2141-2308
  • DOI: 10.5897/JMA
  • Start Year: 2009
  • Published Articles: 160

Review

Group B streptococcus infection and diabetes: A review

Hidekatsu Yanai1,2*, Hidetaka Hamasaki1, Naonori Tsuda1, Hiroki Adachi1, Reo Yoshikawa1, Sumie Moriyama1, Yoshinori Masui1, and Shuichi Mishima1
  1Department of Internal Medicine, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan. 2Clinical Research Center, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
Email: [email protected]

  •  Accepted: 12 September 2011
  •  Published: 31 January 2012

Abstract

 

Streptococcus agalactiae, a group B streptococcus (GBS), has been considered to be a major pathogen in neonates and pregnant women. Recently, there is accumulating concern about its significance for pathogenesis in non-pregnant adult patients. Diabetes is one of the most important underlying diseases for the development of GBS infection. This review will focus on the risk factors and clinical manifestations of GBS infections, and also introduce two patients with hyperglycemic hyperosmolar syndrome and diabetic ketosis who were complicated with pneumonia due to GBS.

 

Key words: Diabetic ketosis, group B streptococcus (GBS), hyperglycemic hyperosmolar syndrome, pneumonia